Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Franklin Resources

LyondellBasell Industries

Altria

Verizon

24/7 Wall St. Insights: The venerable S&P 500 is poised for another year of 20% + gains Many of the stocks in the index have underperformed the red-hot Magnificent 7 Passive income is simple- own quality dividends that pay you for doing nothing.

The 5 Highest Yielding S&P 500 Dividend Stocks Are Passive Income Kings

B&G Foods

Kraft Heinz

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields

Walgreens faces ongoing financial challenges, including a potential future dividend cut, despite recent progress in cost-cutting and debt reduction. The company's 11.9% dividend yield is not covered by free cash flow, with legal fees and operational costs impacting cash flow sustainability. Management's turnaround efforts, including store closures and asset monetization, show promise but will take years to fully materialize.

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Agree Realty

Dollar General

Coca-Cola

Realty Income Corp

PepsiCo

U.S. Bancorp

PepsiCo and Realty Income have experienced price drops due to high inflation, but both companies remain fundamentally sound with strong long-term growth potential. Food inflation, in particular, has continued to weigh on consumer discretionary stocks like PepsiCo and Coca-Cola. PepsiCo's current valuation offers a forward P/E of 20.24x, below its 5-year average, making it an attractive buy near $160 for potential upside.

One Stock I've Been Buying This Month And One I'm Looking To Buy

The latest trading day saw Walgreens Boots Alliance (WBA) settling at $9.03, representing a +0.22% change from its previous close.

Walgreens Boots Alliance (WBA) Surpasses Market Returns: Some Facts Worth Knowing

Medical Properties Trust

Investors can find better dividend options than these two.

2 Dividend-Paying Stocks Income Investors Should Avoid

Walgreens' recent 57% stock decline, dividend cut, and poor reinvestment opportunities indicate it's not in deep value territory and may face further pain. WBA's high debt levels, with free cash flow dropping drastically, suggest another dividend cut is likely despite their capital allocation plan. The Company's focus on debt reduction and reinvestment is problematic due to poor historical returns on invested capital.

Walgreens: Deep Value? Or Massive Value Trap?

The struggling pharmacy retailer still has a tough road ahead.

Walgreens Is Closing 1,200 Stores and Investors Should Expect Even More Big Moves in the Future

Dollar Tree

Estee Lauder

Intel

Moderna

Perhaps this list is a good place to start bargain-hunting.

These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over

Veeva Systems

VEEV partners with Walgreens to provide better patient outcomes to life sciences companies.

Veeva Systems Collaborates With Walgreens to Improve Patient Outcomes

FuboTV

Spirit Airlines

These stocks have all lost more than 80% of their value in the past five years.

3 of the Scariest Stocks to Be Holding Right Now

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has launched the 2024-2025 Walgreens Flu Index, an online, interactive tool that tracks weekly flu activity based on flu-related prescription data across the company's community pharmacy locations nationwide. For 11 years, the Walgreens Flu Index has provided an early and accurate view of disease trends. Historical data from the Walgreens Flu Index shows that southern states tend to see earlier and steeper peaks in flu activity when compared to the re.

Walgreens Launches Annual Flu Index to Help Communities Track Flu Activity

Flowers Foods

Wall Street's Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields

Walgreens Boots Alliance's forward yield hovers around 10.8%, the highest among the S&P 500 index. Such yield raises concerns about a potential dividend trap due to bleak growth prospects and financial struggles, as reported in its recent Q4 earnings. Its Q4 earnings reveal significant challenges, including store closures and a bleak EPS growth outlook.

Walgreens Q4: 2 Signs Of A Dividend Trap

DEERFIELD, Ill.--(BUSINESS WIRE)--To celebrate the service and commitment of the nation's military and honor those who serve the country, Walgreens is offering a four-day in-store discount to all veterans, active-duty military personnel and their family members. Beginning Friday, Nov. 8 through Monday, Nov. 11, veterans, military and their families will receive 20 percent off regular price eligible store items* at any Walgreens or Duane Reade drugstore nationwide. Additionally, through the myWa.

Walgreens Honors Veterans, Active Duty Military and Families with Veterans Day Discount Friday, November 8 through Monday, November 11

Uber

SAN FRANCISCO , Oct. 29, 2024 /PRNewswire/ -- Uber Eats (NYSE:UBER) today announced the arrival of a new initiative to expand access to more nutritious food for millions of Americans. Available now, Uber Eats is accepting SNAP (Supplemental Nutrition Assistance Program) EBT (Electronic Benefits Transfer) payments, starting with the regional grocery banners Albertsons, Safeway, Jewel-Osco and Vons as well as Walgreens locations nationwide and Duane Reade stores exclusively in New York.

Uber Eats Now Accepting SNAP EBT Nationwide With Albertsons Companies, Walgreens

Amcor Plc

BASF SE

Ford Motor Company

Wendy's

24/7 Wall St. Insights The market is the most expensive in almost 40 years.

5 Well-Known High-Yield Blue Chip Dividend Stocks That Cost Less than $20

Shareholders were spooked about a new threat to the company's core business; a fresh dividend declaration didn't help.

Why Investors Were Bailing Out of Walgreens Boots Alliance This Week

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the previous quarter. The dividend is payable on Dec. 12, 2024, to stockholders of record as of Nov. 18, 2024. Walgreens Boots Alliance and its predecessor company, Walgreen Co., have paid a dividend in 368 straight quarters (92 years). About Walgreens Boots Alliance Walgreens Boots Alliance (Nasdaq: WB.

Walgreens Boots Alliance Declares Quarterly Dividend

Walgreens and Veeva Form Strategic Partnership

Walgreens recently announced it would be closing 1,200 stores over the next few years.

Is Walgreens Boots Alliance Stock a Buy After Having Its Best Day in Years?

Walgreens Boots Alliance is significantly undervalued, trading at low P/E multiples and a 44% discount to its book value, with strong upside potential. New CEO Tim Wentworth's cost-cutting strategy and potential sale of VillageMD are expected to boost cash flow and equity value. Conservative valuation models (DCF, trading comps, exit multiple, GGM) indicate WBA is worth at least $28 per share, making it a strong buy.

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Shares of pharmacy giant Walgreens Boots Alliance (WBA) tumbled on Tuesday after investment bank TD Cowen cut its price target on the stock to $14 from $16.

Walgreens Stock Slides as Analysts Question Store-Closure Impact

The stock couldn't hold on to its post-earnings rally, as the threat of online competition came to the fore again.

Why Walgreens Boots Alliance Plunged Again Today

The Dream Vault will provide free, high-quality produce to more than 175 local households per week CHICAGO , Oct. 22, 2024 /PRNewswire/ -- To improve health equity and food security in the Chicago market, Walgreens is joining forces with non-profit Dion's Chicago Dream to host a Dream Vault smart locker at the company's Gage Park location at 55th and Kedzie (5435 S. Kedzie Avenue Chicago, IL).

News for Walgreens Stock (WBA)